The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers
- PMID: 159352
- DOI: 10.1016/s0022-3476(79)80302-9
The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers
Abstract
Eleven infants of diabetic mothers with hypertrophic cardiomyopathy have been followed for 30 to 40 months. All infants presented with cardiorespiratory distress and were found to have disproportionate septal hypertrophy on echocardiogram. Cardiac catheterization was done in four infants; three had significant subaortic obstruction. One infant had remarkable improvement after treatment with propranolol. Two infants who received digoxin did poorly and responded favorably to cessation of therapy. The natural history of HCM-IDM appears to be benign, with a resolution of symptoms within two to four weeks and a resolution of septal hypertrophy within two to 12 months. Most of the infants need only supportive care; if pharmacologic intervention is deemed necessary, propranolol appears to be the drug of choice. The natural history of this entity is that of spontaneous regression of symptoms and septal hypertrophy irrespective of therapy.
Similar articles
-
Hypertrophic cardiomyopathy in infants: clinical features and natural history.Circulation. 1982 Jan;65(1):7-17. doi: 10.1161/01.cir.65.1.7. Circulation. 1982. PMID: 6458422
-
Transient right sided hypertrophic cardiomyopathy in an infant born to a diabetic mother.Indian J Pediatr. 1996 Sep-Oct;63(5):700-3. doi: 10.1007/BF02730827. Indian J Pediatr. 1996. PMID: 10830045
-
Cardiac septal hypertrophy in hyperinsulinemic infants.J Pediatr. 1980 Mar;96(3 Pt 2):535-9. doi: 10.1016/s0022-3476(80)80862-6. J Pediatr. 1980. PMID: 6444667
-
Echocardiographic profile of infants of diabetic mothers.Eur J Pediatr. 1983 Sep;140(4):311-5. doi: 10.1007/BF00442671. Eur J Pediatr. 1983. PMID: 6226528
-
Hypertrophic cardiomyopathy in infants of diabetic mothers: an update.Am J Perinatol. 1988 Oct;5(4):353-8. doi: 10.1055/s-2007-999722. Am J Perinatol. 1988. PMID: 2971360 Review.
Cited by
-
Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.J Perinatol. 2021 Jan;41(1):126-133. doi: 10.1038/s41372-020-00824-7. Epub 2020 Sep 19. J Perinatol. 2021. PMID: 32951013
-
Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes.Pediatr Res. 2017 Nov;82(5):768-775. doi: 10.1038/pr.2017.140. Epub 2017 Jun 28. Pediatr Res. 2017. PMID: 28604759 Free PMC article.
-
Fatal hypertrophic cardiomyopathy in an infant of a diabetic mother.Pediatr Cardiol. 1990 Oct;11(4):211-2. doi: 10.1007/BF02238369. Pediatr Cardiol. 1990. PMID: 2274449
-
Features and outcomes in utero and after birth of fetuses with myocardial disease.Int J Pediatr. 2010;2010:628451. doi: 10.1155/2010/628451. Epub 2010 Oct 3. Int J Pediatr. 2010. PMID: 20976307 Free PMC article.
-
Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy.Biol Sex Differ. 2016 Nov 25;7:63. doi: 10.1186/s13293-016-0118-2. eCollection 2016. Biol Sex Differ. 2016. PMID: 27924218 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources